For COVID-19 positive patients who are moderately ill requiring supplemental oxygen.
Less common (less than 2%):
No clinical interaction studies have been performed with remdesivir.
Decrease therapeutic effect of Remdesivir:
Duration of therapy is 5 days.
IV infusion should occur over 30-120 minutes.
Antimicrobial class: Antiviral, adenosine nucleotide prodrug
Pregnancy category: Unknown - Use only if potential benefit justified potential risk to mother and fetus
Average Serum half life: 1 hour